Sale!

EXT1 Gene Exostoses multiple type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EXT1 Gene Exostoses Multiple Type 1 Genetic Test is a specialized diagnostic tool designed to detect mutations in the EXT1 gene, which are associated with Hereditary Multiple Exostoses (HME) type 1, a genetic disorder characterized by the growth of multiple benign bone tumors. These tumors, known as exostoses or osteochondromas, primarily affect the growth of long bones and can lead to pain, deformity, and potential complications such as nerve compression.

This test is crucial for individuals with a family history of HME or those exhibiting symptoms suggestive of the condition, as early detection can lead to better management and treatment strategies. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test provides a thorough analysis of the EXT1 gene to identify mutations that cause the disorder.

The cost of the EXT1 Gene Exostoses Multiple Type 1 Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to ascertain the presence of genetic mutations in the EXT1 gene, offering invaluable insights for affected individuals and their families. With the results, healthcare providers can develop a more informed approach to the management and treatment of Hereditary Multiple Exostoses, improving the quality of life for those diagnosed with this condition.

Description

EXT1 Gene Exostoses multiple type 1 Genetic Test

Test Name: EXT1 Gene Exostoses multiple type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EXT1 Gene Exostoses, multiple, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EXT1 Gene Exostoses, multiple, type 1 NGS Genetic DNA Test gene EXT1

Test Details: The EXT1 gene is responsible for producing a protein that plays a role in the normal development and maintenance of bones and tissues. Mutations in the EXT1 gene can lead to a condition called hereditary multiple exostoses, type 1 (EXT1 HME), also known as multiple osteochondromas. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that can analyze multiple genes simultaneously. In the case of EXT1 HME, NGS genetic testing can identify mutations or variations in the EXT1 gene that may be associated with the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of EXT1 HME in individuals suspected of having the condition. It can also provide valuable information about the specific mutation present, which can aid in understanding the inheritance pattern, prognosis, and potential complications associated with the condition. NGS genetic testing for EXT1 HME can be performed using a blood or saliva sample. The sample is sent to a laboratory, where the DNA is extracted and analyzed using NGS technology. The resulting data is then interpreted by geneticists and genetic counselors to provide a comprehensive report on the individual’s genetic findings. It is important to note that NGS genetic testing is not a diagnostic tool on its own. The results of the test should be interpreted in conjunction with the individual’s clinical presentation, family history, and other relevant factors. Genetic counseling is often recommended before and after testing to discuss the implications of the results and provide guidance on appropriate management and treatment options.

Test Name	EXT1 Gene Exostoses multiple type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for EXT1 Gene Exostoses, multiple, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EXT1 Gene Exostoses, multiple, type 1 NGS Genetic DNA Test gene EXT1
Test Details	The EXT1 gene is responsible for producing a protein that plays a role in the normal development and maintenance of bones and tissues. Mutations in the EXT1 gene can lead to a condition called hereditary multiple exostoses, type 1 (EXT1 HME), also known as multiple osteochondromas. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that can analyze multiple genes simultaneously. In the case of EXT1 HME, NGS genetic testing can identify mutations or variations in the EXT1 gene that may be associated with the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of EXT1 HME in individuals suspected of having the condition. It can also provide valuable information about the specific mutation present, which can aid in understanding the inheritance pattern, prognosis, and potential complications associated with the condition. NGS genetic testing for EXT1 HME can be performed using a blood or saliva sample. The sample is sent to a laboratory, where the DNA is extracted and analyzed using NGS technology. The resulting data is then interpreted by geneticists and genetic counselors to provide a comprehensive report on the individual’s genetic findings. It is important to note that NGS genetic testing is not a diagnostic tool on its own. The results of the test should be interpreted in conjunction with the individual’s clinical presentation, family history, and other relevant factors. Genetic counseling is often recommended before and after testing to discuss the implications of the results and provide guidance on appropriate management and treatment options.